NONMEM Users Network Archive

Hosted by Cognigen

Open position at Seattle Genetics - Pharmacokineticist/Sr. Pharmacokineticist

From: Tae Han <than>
Date: Wed, 6 Feb 2013 20:59:03 +0000

Put your passion to work at Seattle Genetics
The strength of the Seattle Genetics team resides in our collective commitm=
ent to patient care, individual excellence and teamwork.

Seattle Genetics is seeking a bright and motivated pharmacokineticist to jo=
in our Clinical Pharmacology Department
- Advance the science of novel antibody-based drug candidates through the d=
esign, analysis, and interpretation of clinical pharmacokinetic (PK) and ph=
armacokinetic/pharmacodynamic (PK/PD) studies.
- Aid in the development of novel drug candidates by preparing PK, PK/PD, p=
opPK, and/or modeling and simulation components of study protocols, reports=
, project summaries, development plans, and regulatory submissions.
- Collaborate with drug development teams by serving as a key contact for P=
K and PK/PD related issues and providing the PK and PK/PD perspective of dr=
ug candidates.
- Advanced degree (Ph.D., Pharm. D., and/or M.D.) in Biomedical, Biological=
 or Pharmaceutical Science/Engineering with 1 - 4 years of industry experie=
- In depth knowledge of PK and PK/PD concepts with a strong clinical pharma=
cology background.
- Proficiency in PK and PK/PD analysis using WinNonLin or equivalent softwa=
re is a pre-requisite.
- Excellent oral and written communication skills and a proven track record=
 of working effectively in a dynamic, collaborative, team-oriented setting.
- Previous experience with monoclonal antibodies.
- Experience with population PK/PD analysis using NONMEM or equivalent soft=
- Experience in oncology drug development
- Knowledge of regulatory requirements and experience in communications wit=
h regulatory authorities.

Seattle Genetics is an equal opportunity employer.
If you are interested, please apply through the Seattle Genetics website:


Received on Wed Feb 06 2013 - 15:59:03 EST

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: